Since Pirfenidone is metabolised from the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy is usually to be prevented. Black, tarry stools blistering, peeling, or loosening of the pores and skin chest soreness chills cough or hoarseness fever with https://boceprevir55426.tribunablog.com/indicators-on-notoginsenoside-r1-you-should-know-44069047